Health Products

Tian Ma Tu Chung Seven Leave Ginseng, Vall-Boon Tongkat Ali, and Pao Ni Kang

· Published by Health Canada · Official notice

Details

Alert type: Foreign Product Alert (FPA)
Category: Natural health products
Issue: Undeclared Substance, Product Safety
Audience: General Public
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Images

Details

These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Source of alert

Singapore Health Sciences Authority (HSA)

Product names

  • Tian Ma Tu Chung Seven Leave Ginseng
  • Vall-Boon Tongkat Ali
  • Pao Ni Kang

Manufacturer / Place of origin

Tian Ma Tu Chung Seven Leave Ginseng is distributed by Ving Hong Enterprise, of Perak, Malaysia.

Vall-Boon Tongkat Ali is manufactured and distributed by Vall-Boon Medical Factory Sdn Bhd, of Penang, Malaysia.

Pao Ni Kang is manufactured by Shitek Micro Algae Sdn Bhd, of Selangor, Malaysia, and distributed by High Mean (M) Sdn Bhd, of Kuala Lumpur, Malaysia.

Product description

These products are promoted as traditional herbal medicines.

Tian Ma Tu Chung Seven Leave Ginseng is packaged in a bottle of 48 black round pills. The product label claims to treat pain and numbness ("Used for lumbar and leg pains, rheumatoid arthritis, muscular and osseous atony and limb numbness. Helps to relax muscles, invigorate blood circulation, expel flatulence and relieve pains.").

Vall-Boon Tongkat Ali is packaged in a bottle of 35 brown capsules and claims to relieve fatigue ("Sustain good health, relieve fatigue or tiredness, and slow aging.").

Pao Ni Kang is packaged in a bottle containing 80 yellow capsules. The product claims to invigorate vital energy ("Traditionally used to invigorate vital energy, and for sweating.").

Reason for warning

The HSA warned consumers not to use these products after they were found to contain undeclared pharmaceutical ingredients:

Affected Foreign Products
Product Undeclared Ingredient
Tian Ma Tu Chung Seven Leave Ginseng
  • dexamethasone
  • chlorpheniramine
Vall-Boon Tongkat Ali
  • dexamethasone
  • chlorpheniramine
  • ketoconazole
  • pheniramine
Pao Ni Kang
  • repaglinide

Dexamethasone is a steroidal prescription drug used to treat inflammatory conditions such as arthritis and allergic reactions, while ketoconazole is an oral anti-fungal prescription drug used to treat serious systemic and skin fungal infections, and repaglinide is a prescription drug used to treat diabetes. These drugs should only be taken under the supervision of a health care practitioner.

Chlorpheniramine and pheniramine are over-the-counter antihistamine drugs.

The HSA investigated these products after receiving reports of side effects from Singapore consumers:

Tian Ma Tu Chung Seven Leave Ginseng: A patient in her 60s suffered Cushing's syndrome after using this product for about one month. Symptoms included puffy face, hump back and high blood pressure. The patient also experienced hallucination and memory loss.

Vall-Boon Tongkat Ali: A patient in his 20s suffered symptoms of Cushing's syndrome, such as thinning of the skin and appearance of red stretch marks all over his body. The patient also experienced withdrawal symptoms when he tried to stop using the product (persistent headaches and insomnia).

Pao Ni Kang: A diabetic patient in his 30s was hospitalized after he developed serious symptoms of low blood sugar (confusion, giddiness and slurred speech).

Possible side effects

Side effects associated with dexamethasone include irregular heartbeat, increased blood pressure, stomach ulcer, blood disorders, skin, muscle and bone damage, and nervous system disorders. Consult with your health care practitioner prior to stopping use, as sudden discontinuation of dexamethasone may cause symptoms of withdrawal.

Side effects associated with ketoconazole include skin rash, abdominal pain, heartburn, nausea and vomiting. Less common side effects include headache, dizziness, tremors, increased hormone levels, intestinal bleeding, and liver dysfunction.

Side effects associated with repaglinide include severe low blood sugar which may cause sweating, increased heartbeat, paleness, chills, headache, dizziness and confusion.

Side effects associated with chlorpheniramine and pheniramine include drowsiness, dizziness, confusion and blurred vision.

What you should do

Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed above in the Canadian marketplace.

Background

Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.

Report a health or safety concern

  • Call toll-free at 1-866-234-2345.
  • Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

Media enquiries

Health Canada
613-957-2983

Public enquiries

613-957-2991
1-866-225-0709

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime